Manufacturers Life Insurance Company, The Crinetics Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 134,087 shares of CRNX stock, worth $7.23 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
134,087
Previous 131,063
2.31%
Holding current value
$7.23 Million
Previous $5.87 Million
16.68%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding CRNX
# of Institutions
241Shares Held
79.5MCall Options Held
23.3KPut Options Held
44.3K-
Vanguard Group Inc Valley Forge, PA6.29MShares$339 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$336 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.89MShares$317 Million2.95% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.94MShares$267 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA4.46MShares$241 Million0.04% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.9B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...